— This week’s episode of “WisBusiness: the Podcast” is with Goutham Narla, chief scientific officer for WARF Therapeutics and founder of Rappta Therapeutics. He joined WARF in April, taking over for former WARF Therapeutics leader Jon Young. Meanwhile, Narla highlights his work with the drug development firm Rappta Therapeutics. Narla also emphasizes the concrete impact on patients from WARF’s drug development efforts. We Energies spokesperson Brendan Conway wrote in an email that the utility’s power plants will consume 25% to 30% less water than they did in 2015.